Sidley Represents Haystack Sciences in Sale to insitro

Oct 27, 2020

Posted by Sidley Austin

Sidley represented Haystack Sciences in its acquisition by insitro, a machine learning-driven drug discovery and development company. Haystack Sciences is a private company focused on advancing proprietary methods to drive machine learning-enabled drug discovery. Haystack Sciences was incubated at the Illumina Accelerator and is backed by leading investors including Viking Global Investors, Nimble Ventures, HBM Genomics, and Illumina.  Learn more here.

See all Member News